LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 232 filers reported holding LOXO ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is 0.50 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $2,322,000 | -20.8% | 13,593 | -19.6% | 0.34% | -25.3% |
Q2 2018 | $2,932,000 | +2.2% | 16,903 | -32.0% | 0.46% | -3.3% |
Q1 2018 | $2,869,000 | -33.7% | 24,865 | -47.1% | 0.48% | -16.9% |
Q3 2017 | $4,329,000 | -27.2% | 46,993 | -36.6% | 0.58% | -41.5% |
Q2 2017 | $5,945,000 | +37.0% | 74,140 | -28.1% | 0.98% | +43.7% |
Q1 2017 | $4,341,000 | +21.5% | 103,149 | -7.3% | 0.68% | +44.0% |
Q4 2016 | $3,573,000 | +60.4% | 111,268 | +30.8% | 0.48% | +58.9% |
Q3 2016 | $2,227,000 | -51.9% | 85,061 | -57.4% | 0.30% | -57.0% |
Q2 2016 | $4,630,000 | -21.2% | 199,730 | -7.0% | 0.70% | -24.3% |
Q1 2016 | $5,874,000 | +88.0% | 214,859 | +95.6% | 0.92% | +124.7% |
Q4 2015 | $3,125,000 | +45.9% | 109,855 | -10.4% | 0.41% | +20.6% |
Q3 2015 | $2,142,000 | +54.7% | 122,552 | +59.6% | 0.34% | +109.3% |
Q2 2015 | $1,385,000 | – | 76,807 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital LLC | 3,452,493 | $45,330,000 | 8.79% |
BVF INC/IL | 1,192,202 | $15,654,000 | 3.25% |
Redmile Group, LLC | 540,300 | $7,094,000 | 0.82% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,591,546 | $20,897,000 | 0.76% |
Orbimed Advisors | 2,175,857 | $28,569,000 | 0.30% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 365,566 | $4,800,000 | 0.18% |
MARXE AUSTIN W & GREENHOUSE DAVID M | 75,000 | $985,000 | 0.13% |
RS INVESTMENT MANAGEMENT CO LLC | 599,400 | $7,870,000 | 0.07% |
Visium Asset Management, LP | 332,516 | $4,366,000 | 0.06% |
Nicholas Investment Partners, LP | 73,341 | $963,000 | 0.06% |